The move also earned Hikma an upgrade to ‘buy’ from analysts at Jefferies, who said the addition of the new products would help the company accelerate a turnaround in its US injectable ...

Hikma Pharmaceuticals Usa Inc was founded in 2011 and operates in Eatontown, United States. The company engages in the sector 'Pharmaceuticals, Medicinal Chemical & Botanical Products' (ISIC ...

Vectura and Hikma have extended their partnership, signing an agreement to develop a generic of GlaxoSmithKline’s asthma drug, Serevent, for the US market. The product is codenamed VR730 ...

London, United Kingdom – Hikma Pharmaceuticals PLC (Hikma ... We are also benefitting from sustained good demand for our own products in Europe, including in our new markets. Our MENA Injectables ...

Analyst Christian Glennie from Stifel Nicolaus reiterated a Buy rating on Hikma Pharmaceuticals (HIK – Research Report) and keeping the ...

Welcome to the Southern New Hampshire University Academic Catalog. Use the menu to navigate the catalog, and learn more about SNHU programs, courses and policies. Note: It's a good idea for all ...

The acquisition will add eight approved and marketed injectable products to Hikma's US portfolio, and 11 pipeline products.

Hikma Pharmaceuticals (GB:HIK) has released an update. Hikma Pharmaceuticals has decided to reappoint PricewaterhouseCoopers LLP as its external auditor starting in 2026, following a competitive ...

Shares of Hikma Pharmaceuticals PLC HIK inched down 0.99% to £19.98 Friday, on what proved to be an all-around dismal trading session for the stock market, with the FTSE 100 Index UKX falling 0. ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.